Volume 28; Issue 7

Main
Leukemia
Volume 28; Issue 7

Leukemia

Volume 28; Issue 7

1

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Tefferi, A, Lasho, T L, Finke, C M, Knudson, R A, Ketterling, R, Hanson, C H, Maffioli, M, Caramazza, D, Passamonti, F, Pardanani, A

Journal:

Year:

2014

Language:

english

File:

PDF, 1.03 MB

english, 2014

2

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

Tefferi, A, Thiele, J, Vannucchi, A M, Barbui, T

Journal:

Year:

2014

Language:

english

File:

PDF, 1.11 MB

english, 2014

3

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

Panagiota, V, Thol, F, Markus, B, Fehse, B, Alchalby, H, Badbaran, A, Lehmann, U, Koenecke, C, Shahswar, R, Chaturvedi, A, Stadler, M, Eder, M, Göhring, G, Koenigsmann, M, Kloos, A, Trummer, A, Schroe

Journal:

Year:

2014

Language:

english

File:

PDF, 606 KB

english, 2014

4

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Tefferi, A, Guglielmelli, P, Lasho, T L, Rotunno, G, Finke, C, Mannarelli, C, Belachew, A A, Pancrazzi, A, Wassie, E A, Ketterling, R P, Hanson, C A, Pardanani, A, Vannucchi, A M

Journal:

Year:

2014

Language:

english

File:

PDF, 1.14 MB

english, 2014

5

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact

Tefferi, A, Lasho, T L, Finke, C, Belachew, A A, Wassie, E A, Ketterling, R P, Hanson, C A, Pardanani, A

Journal:

Year:

2014

Language:

english

File:

PDF, 180 KB

english, 2014

6

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

Schultz, K R, Carroll, A, Heerema, N A, Bowman, W P, Aledo, A, Slayton, W B, Sather, H, Devidas, M, Zheng, H W, Davies, S M, Gaynon, P S, Trigg, M, Rutledge, R, Jorstad, D, Winick, N, Borowitz, M J, H

Journal:

Year:

2014

Language:

english

File:

PDF, 292 KB

english, 2014

7

High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome

Krauth, M-T, Eder, C, Alpermann, T, Bacher, U, Nadarajah, N, Kern, W, Haferlach, C, Haferlach, T, Schnittger, S

Journal:

Year:

2014

Language:

english

File:

PDF, 742 KB

english, 2014

8

Chromatin modifiers and the promise of epigenetic therapy in acute leukemia

Greenblatt, S M, Nimer, S D

Journal:

Year:

2014

Language:

english

File:

PDF, 1.09 MB

english, 2014

9

How we manage follicular lymphoma

Hiddemann, W, Cheson, B D

Journal:

Year:

2014

Language:

english

File:

PDF, 402 KB

english, 2014

10

The CD37-targeted antibody–drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model

Beckwith, K A, Frissora, F W, Stefanovski, M R, Towns, W H, Cheney, C, Mo, X, Deckert, J, Croce, C M, Flynn, J M, Andritsos, L A, Jones, J A, Maddocks, K J, Lozanski, G, Byrd, J C, Muthusamy, N

Journal:

Year:

2014

Language:

english

File:

PDF, 2.07 MB

english, 2014

11

Efficacy of cyclin-dependent-kinase 9 inhibitors in a murine model of mixed-lineage leukemia

Garcia-Cuellar, M-P, Füller, E, Mäthner, E, Breitinger, C, Hetzner, K, Zeitlmann, L, Borkhardt, A, Slany, R K

Journal:

Year:

2014

Language:

english

File:

PDF, 3.74 MB

english, 2014

12

MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure

Agrawal, M, Hanfstein, B, Erben, P, Wolf, D, Ernst, T, Fabarius, A, Saussele, S, Purkayastha, D, Woodman, R C, Hofmann, W-K, Hehlmann, R, Hochhaus, A, Müller, M C

Journal:

Year:

2014

Language:

english

File:

PDF, 831 KB

english, 2014

13

Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities

Journal:

Year:

2014

Language:

english

File:

PDF, 439 KB

english, 2014

14

Calreticulin mutation was rarely detected in patients with myelodysplastic syndrome

Hou, H-A, Kuo, Y-Y, Chou, W-C, Chen, P-H, Tien, H-F

Journal:

Year:

2014

Language:

english

File:

PDF, 661 KB

english, 2014

15

Update on second primary malignancies in multiple myeloma: a focused review

Landgren, O, Mailankody, S

Journal:

Year:

2014

Language:

english

File:

PDF, 264 KB

english, 2014

16

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome

Chilton, L, Buck, G, Harrison, C J, Ketterling, R P, Rowe, J M, Tallman, M S, Goldstone, A H, Fielding, A K, Moorman, A V

Journal:

Year:

2014

Language:

english

File:

PDF, 384 KB

english, 2014

17

A role for oleoylethanolamide in chronic lymphocytic leukemia

Masoodi, M, Lee, E, Eiden, M, Bahlo, A, Shi, Y, Ceddia, R B, Baccei, C, Prasit, P, Spaner, D E

Journal:

Year:

2014

Language:

english

File:

PDF, 823 KB

english, 2014

18

Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+IgM+IgD+ memory B cells with a distinctive immunophenotype

Berkowska, M A, Grosserichter-Wagener, C, Adriaansen, H J, de Ridder, D, Mirani-Oostdijk, K P, Agteresch, H J, Böttcher, S, Orfao, A, van Dongen, J J M, van Zelm, M C

Journal:

Year:

2014

Language:

english

File:

PDF, 859 KB

english, 2014

19

Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23)

Coenen, E A, Zwaan, C M, Stary, J, Baruchel, A, de Haas, V, Stam, R W, Reinhardt, D, Kaspers, G J L, Arentsen-Peters, S T C J M, Meyer, C, Marschalek, R, Nigro, L L, Dworzak, M, Pieters, R, van den He

Journal:

Year:

2014

Language:

english

File:

PDF, 1.99 MB

english, 2014

20

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

Ravandi, F, Arana Yi, C, Cortes, J E, Levis, M, Faderl, S, Garcia-Manero, G, Jabbour, E, Konopleva, M, O'Brien, S, Estrov, Z, Borthakur, G, Thomas, D, Pierce, S, Brandt, M, Pratz, K, Luthra, R, Andree

Journal:

Year:

2014

Language:

english

File:

PDF, 402 KB

english, 2014

21

Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia

Matsuda, K, Nakazawa, Y, Iwashita, C, Kurata, T, Hirabayashi, K, Saito, S, Tanaka, M, Yoshikawa, K, Yanagisawa, R, Sakashita, K, Sasaki, S, Honda, T, Koike, K

Journal:

Year:

2014

Language:

english

File:

PDF, 819 KB

english, 2014

22

Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis

Tabarroki, A, Lindner, D J, Visconte, V, Zhang, L, Rogers, H J, Parker, Y, Duong, H K, Lichtin, A, Kalaycio, M E, Sekeres, M A, Mountantonakis, S E, Heresi, G A, Tiu, R V

Journal:

Year:

2014

Language:

english

File:

PDF, 422 KB

english, 2014

23

Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma

Ramakrishnan, V, Painuly, U, Kimlinger, T, Haug, J, Rajkumar, S V, Kumar, S

Journal:

Year:

2014

Language:

english

File:

PDF, 3.83 MB

english, 2014

24

Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B

Itonaga, H, Imanishi, D, Wong, Y-F, Sato, S, Ando, K, Sawayama, Y, Sasaki, D, Tsuruda, K, Hasegawa, H, Imaizumi, Y, Taguchi, J, Tsushima, H, Yoshida, S, Fukushima, T, Hata, T, Moriuchi, Y, Yanagihara,

Journal:

Year:

2014

Language:

english

File:

PDF, 1.73 MB

english, 2014

25

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Berenson, J R, Hilger, J D, Yellin, O, Dichmann, R, Patel-Donnelly, D, Boccia, R V, Bessudo, A, Stampleman, L, Gravenor, D, Eshaghian, S, Nassir, Y, Swift, R A, Vescio, R A

Journal:

Year:

2014

Language:

english

File:

PDF, 614 KB

english, 2014

26

Serial exome analysis of disease progression in premalignant gammopathies

Zhao, S, Choi, M, Heuck, C, Mane, S, Barlogie, B, Lifton, R P, Dhodapkar, M V

Journal:

Year:

2014

Language:

english

File:

PDF, 583 KB

english, 2014

27

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey

Landgren, O, Graubard, B I, Katzmann, J A, Kyle, R A, Ahmadizadeh, I, Clark, R, Kumar, S K, Dispenzieri, A, Greenberg, A J, Therneau, T M, Melton, L J, Caporaso, N, Korde, N, Roschewski, M, Costello,

Journal:

Year:

2014

Language:

english

File:

PDF, 417 KB

english, 2014

28

A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

Drummond, M W, Pocock, C, Boissinot, M, Mills, J, Brown, J, Cauchy, P, Cross, N C P, Hartley, S, Kell, J, Szubert, A, Cockerill, P N, Bowen, D T

Journal:

Year:

2014

Language:

english

File:

PDF, 164 KB

english, 2014

29

Acute myeloid leukemia cells harboring MLL fusion genes or with the acute promyelocytic leukemia phenotype are sensitive to the Bcl-2-selective inhibitor ABT-199

Niu, X, Wang, G, Wang, Y, Caldwell, J T, Edwards, H, Xie, C, Taub, J W, Li, C, Lin, H, Ge, Y

Journal:

Year:

2014

Language:

english

File:

PDF, 627 KB

english, 2014